Summary:
CNDO 201-003: A PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 12 WEEKS OF TREATMENT WITH ORAL CNDO 201 TRICHURUS OVA SUSPENSION (TSO)AS COMPARED TO PLACEBO, FOLLOWED BY A 12 WEEK OPEN-LABEL TREATMENT PERIOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
Qualified Participants Must:
• Must call the research center to see if they qualify.
Qualified Participants May Receive:
INVESTIGATIONAL THERAPY FOR CROHN'S DISEASE;STUDY-RELATED CARE UP TO $XXX COMPENSATION FOR TIME & TRAVEL.